Insiders · Profile

Arkin Bio Ventures 2 L.P.

10% owner at Werewolf Therapeutics. Filing since 4 May 2021. CIK 0001858705

Company

Date

Role

Action

Shares

Amount

Of holding

HOWL Werewolf Therapeutics, Inc.

4 May 2021

10% owner

Bought

400,000

$6.40M

24.3%

1 decision on file.